Gossamer Bio Inc. (GOSS) Misses Q2 EPS by 29c

Gossamer Bio Inc. (NASDAQ: GOSS) reported Q2 EPS of $0.22, $0.29 worse than the analyst estimate of $0.51. Revenue for the quarter came in at $95.84 million versus the consensus estimate of $114.29 million.

For earnings history and earnings-related data on Gossamer Bio Inc. (GOSS) click here.

You May Also Be Interested In

• Paylocity Holding (PCTY) PT Lowered to $165 at Truist Securities
• KeyBanc: 'We Expect Magnolia Oil & Gas Corp. (MGY) Shares to be Volatile on Monday'
• Sonida Senior Living (SNDA) PT Raised to $48 at RBC Capital